<DOC>
	<DOCNO>NCT00409526</DOCNO>
	<brief_summary>Inhaled Iloprost administer near term infant Persistent Pulmonary Hypertension Newborn two different dos order test safety efficacy reduce pulmonary artery pressure .</brief_summary>
	<brief_title>Inhaled Iloprost Treatment Persistent Pulmonary Hypertension Term Near Term Infants .</brief_title>
	<detailed_description>Infants eligible study divide two arm accord oxygenation index : Infants arm A ( OI &lt; 20 ) receive nebulized Iloprost low dose ( 50 ng/kg/min ) one hour , high dose ( 100 ng/kg/min ) another hour . Infants arm B ( OI &gt; 20 ) receive NO , addition receive nebulized Iloprost low dose one hour high dose another hour .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>Nearterm infant ( &gt; 34 gestational age ) evidence persistent pulmonary hypertension severe hypoxia ( PaO2 &lt; 100 mmHg mechanical ventilation FiO2=100 % ) . Major congenital malformation Congenital diaphragmatic hernia Structural cardiac anomaly Hydrops fetalis Pulmonary hemorrhage Severe perinatal depression Patients high frequency oscillation ventilator</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Days</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Iloprost</keyword>
	<keyword>PPHN</keyword>
	<keyword>Newborn</keyword>
	<keyword>Pulmonary Hypertension</keyword>
	<keyword>Term</keyword>
	<keyword>Persistent Pulmonary Hypertension Newborn</keyword>
</DOC>